A roundup of stories from Penn Today on veterinary research in cancer immunotherapy, hip replacement, retinal disease, and the direct impact of pet CPR.
Nicola Mason, Antonia Rotolo, and Mary Beth Boland with Rex, first dog treated on metastatic osteosarcoma trial.
(Image: John Donges)
The Comparative Immunotherapy Program led by Penn Vet’s Nicola Mason is redefining how therapies are developed and tested—uniting human and veterinary medicine to move promising immunotherapies forward.
Members of Penn Vet’s orthopedic team perform surgery in the Total Hip Replacement Program, including (second from the left) Anna Massie, assistant professor of small animal orthopedic surgery, Jason Syrcle, section chief and professor of clinical small animal orthopedic surgery, and Kimberly Agnello, professor of small animal orthopedic surgery.
(Image: Courtesy of Penn Vet)
Total hip replacement surgery outcomes at Penn Vet have been greatly improved through state-of-the-art technological advances and synergistic programming.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
